脑部放疗，上午比下午敏感许多！
: I0 D2 m6 o# r3 `" J6 K0 V/ U4 Y* T! }- W8 t, f# a$ a
* D# A& Y" D/ T- j% r3 l/ d$ g+ H) a
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
# ~1 O$ j# |( Q! c- V/ AGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?; I( |: N6 e6 X2 t1 X2 u2 D
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T." |8 s" U% M: t
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
4 l3 i+ y6 U2 g& f2 S% O$ J
) B$ k! Y; W$ E+ g# r( ^Abstract
" H9 R) w0 r; V# y* H6 }BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time. ?* U0 n+ S/ S
$ H; ~: y, `1 l/ h# L5 WMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.& F+ `8 S/ K$ V6 [: v
; P6 t4 I' i; ?" Z5 c. KRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
% r4 p* P3 O: }) M0 R5 ~! Y" I' y5 y8 e { r
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
- Z+ ~7 }$ W9 E) I3 F0 F8 ^# H1 [0 x; v1 B
|
! D: S2 I+ v7 a
显身卡
